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ABSTRACT 
Lactate dehydrogenase, a redox-active enzyme with five reactive cysteine 
residues, reversibly converts pyruvate to lactate during anaerobic glycolysis.  In the 
case of certain disease states, when oxygen levels are low or increased oxidative stress 
damages mitochondrial respiration, cells must rely heavily on anaerobic glycolysis for 
ATP production.  This is true of Alzheimer’s disease, Parkinson’s disease, ALS, and 
many cancers. Diseased cells upregulate anaerobic glycolytic enzymes - particularly 
LDH – to produce enough energy to survive. Upregulated LDH plays a key role because 
as it produces lactate, it also replenishes NAD+, allowing for high levels of glycolysis to 
continue uninterrupted. Despite research into the function of LDH as a glycolytic 
enzyme, little focus has been allocated to its role outside of glycolysis and its interaction 
with reactive oxygen species and other cysteine reactive compounds – knowledge of 
which could illuminate further disease mechanics.  
For this project, we first investigated the effects of bleach (HOCl) – a common 
reactive oxygen species found elevated in Alzheimer’s disease – on LDH structure and 
function. We then examined the effects of oxidized plant-derived phenolic antioxidants 
on LDH activity. Research shows that catechol-based antioxidants are readily oxidized 
by radicals to quinones. These quinones can further react with protein thiols, 
demonstrating the potential for beneficial antioxidants to become damaging pro-
oxidants, and thus prompting our investigation into their reactivity with LDH cysteine 
residues. We compared our results with LDH to those obtained using alcohol 
dehydrogenase (ADH), a model protein that also contains readily oxidized cysteine 
residues. In our work we utilized UV/Vis spectroscopy, fluorescence spectroscopy, and 
SDS-PAGE techniques to examine how LDH and ADH structure and function changed 
when respective available protein thiols were reacted with HOCl or oxidized plant-
derived phenolic antioxidants. Resulting data confirms these compounds inhibit LDH 
and ADH activity, strongly suggesting that modification of key cysteine residues occurs, 
changing the conformation of the protein. 
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INTRODUCTION 
 Glycolytic enzymes including lactate dehydrogenase (LDH), glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), and pyruvate kinase (PK) are abundant in nearly 
all cell types and all contain reduced cysteine residues which are readily oxidized by 
various compounds found both endogenously in cells and exogenously in medicines, 
pollutants, and cancerous agents (Foley et. al. 2014). Little research has characterized 
the dynamic and diverse functions of these enzymes in disease contexts. In this paper, 
we investigated LDH in the context of Alzheimer’s disease (AD) and ageing. We 
examined LDH with respect to the following reaction types: 1. HOCl modification of 
cysteine residues, 2. glutathione scavenging of radicals and modification of cysteine 
residues, and 3. the potential for antioxidants to become pro-oxidants and bind 
irreversibly to cysteine residues. In the third case, we specifically investigated the 
oxidative capabilities of ortho-quinones, or oxidized catechol-based derivatives 
(common antioxidants found in all or most plants). We then compared our results with 
similar experiments done in our lab on alcohol dehydrogenase (ADH), a model protein 
found in yeast cells. 
 Cellular disease states depend on tightly regulated energy production. Thus, 
enzymes involved in energy production – such as glycolytic enzymes – are very 
important in maintaining disease conditions. For example, in tumor cells where oxygen 
is not readily available, the cell cannot rely on mitochondrial respiration (in which 
oxygen is required).  Glycolysis levels are elevated to compensate for expected energy 
loss. This is called the Warburg effect (Vander Heiden, 2009). In this process, anaerobic 
glycolysis is upregulated (this includes LDH, GAPDH, and PK enzymes). Hypoxia-
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inducible transcription factor (HIF-1) becomes stabilized under hypoxic conditions and 
binds to DNA, inducing transcription of the major glycolytic genes. To allow for 
continuous glycolytic function, LDH regenerates the cofactor nicotinamide adenine 
dinucleotide (NAD+) through a process called lactic acid fermentation (Kim, 2005). 
 In Alzheimer’s disease, a similar outcome occurs when the accumulation of 
plaques in the brain causes increased oxidative stress and subsequent damage to 
neuronal mitochondria (Whiteman et. al., 2005). Successful energy production depends 
on the upregulation of the glycolytic pathway since damaged mitochondria cannot 
effectively sustain mitochondrial respiration. Again, the upregulation of LDH is 
necessary to regenerate NAD+.  
Figure 1: Energy production via anaerobic glycolysis versus via cellular 
respiration 
  
Although oxidative phosphorylation produces more ATP than glycolysis, ROS damage to the 
mitochondria, and/or a lack of oxygen, can induce the cell to rely more heavily on glycolysis (located in 
the cytosol). The Warburg Effect in hypoxic tumor environments exemplifies this shift (Vander Heiden, 
2009). (Image from Vander Heiden, 2009). 
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 The goal of this research was to characterize how oxidative agents damage LDH 
– specifically how LDH’s five cysteine residues can be modified by biologically relevant 
oxidants like hypochlorous acid (HOCl), and how these modifications affect protein 
activity and conformation. We hypothesized that damaging oxidative agents like HOCl 
and oxidized phenolic compounds would modify LDH cysteine residues and negatively 
affect LDH activity. By exploring the extent to which different compounds interact with 
LDH, the enzyme’s behavior could be characterized, in vitro, using simulated disease 
environments. We were able to determine if damage we caused to the enzyme could be 
reversed, as well as whether we could protect the protein from the damaging agents 
prior to exposure.  
 There is still no cure for most neurodegenerative diseases, and there is no 
comprehensive understanding of ageing. By examining proteins that are conserved 
across cell types and that play important roles in metabolism – especially during times 
of cellular stress – scientists can further elucidate how these proteins function in 
disease states. The results of these experiments are useful in that they add to the 
knowledge scientists have been building regarding diseases of aging, showing how 
lactate dehydrogenase responds in AD conditions, and how key model proteins can be 
affected negatively by the products of antioxidant processes.  
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BACKGROUND 
The background of this paper will focus on the relevance of this research to 
Alzheimer’s disease, reactive oxygen species and antioxidants, the function of 
anaerobic glycolysis in disease states, lactate dehydrogenase’s structure and function, 
the importance of thiol biochemistry and redox regulation in mammalian cells, and the 
three types of reactions this research is primarily concerned with: HOCl modification of 
cysteine residues, glutathione competition for reactive oxygen species, and modification 
of cysteine residues via quinone chemistry. 
Alzheimer’s disease pathology 
Alzheimer’s disease (AD) is a neurodegenerative brain disorder characterized by 
extracellular amyloid beta (Aβ) plaques and intracellular neurofibrillary tangles 
(Alzheimer’s Association, 2016). Early symptoms of AD include memory loss, inability to 
perform daily tasks, and difficulty communicating. As AD progresses through the brain, 
patients experience personality changes, delusions, hallucinations, loss of muscle 
control, and eventual death. Currently, there is no cure for AD. It is the sixth leading 
cause of death in America, and in 2016, the costs associated with AD care were $236 
billion (Alzheimer’s Association, 2016. Further research into AD mechanisms is 
imperative for mitigating the effects of this disease. 
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Figure 2: AD Progression from Moderate AD to Severe AD in Brain Cross-Section 
(National Institute on Ageing) 
 
Over time, neurons affected by AD become isolated and unable to communicate with surrounding cells. 
This results in significant shrinkage of key brain areas such as the hippocampus and cerebral cortex. 
(Image from the National Institute on Aging). 
 
Although research has successfully elucidated important elements of AD 
progression, no comprehensive description of an AD mechanism exists. The abnormal 
regulation of glycolysis in AD may play a key role in AD progression. Knowledge of this 
could help connect current AD research on oxidative stress, plaques, and neuron death. 
Neurofibrillary Tangles and AD 
Neurofibrillary tangles are insoluble, twisted fibers consisting of tau protein (Iba, 
2013). They are found in the neurons of AD patients. In a normal brain, tau is a 
component of microtubules, an important structural protein in cells. In an AD brain state, 
abnormal tau causes the microtubules to collapse and aggregate. Although researchers 
do not know if these tangles are a result of AD conditions, or a cause of AD conditions, 
they are present in the brains of AD patients. 
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Figure 3: Neurofibrillary Tangles (Healthy vs. Diseased Brain) (National 
Institutes of Ageing) 
 
Neurofibrillary tangles occur within neurons when microtubules disintegrate, aggregate, and become 
insoluble tangles. These tangles disrupt cellular functions. (Image from the National Institute on Aging). 
 
Amyloid Beta (Aβ) Peptides Form Aβ Plaques 
Aβ plaques are insoluble accumulations of β-amyloid protein between neurons, 
and are a characteristic of AD patients’ brains (Vlassenko, 2014). β-amyloid peptide 
fragments originate from a larger transmembrane amyloid precursor protein (APP). In 
normal brains, APP is broken down by gamma secretase, a protease specialized for 
cleaving single-pass transmembrane proteins. After cleavage, the short peptides are 
eliminated from the cell. In AD brains, APP is improperly broken apart due to mutated 
gamma secretases that cleave a shorter peptide from APP. The most common isoform 
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of gamma secretase is Aβ40, but Aβ42 leads to misfolding of Aβ cleaved peptides. This 
misfolding, in turn, leads to Aβ plaques. The accumulations of Aβ plaques can occur 
between 10 to 15 years prior to the onset of recognizable AD symptoms and AD 
diagnosis. 
Figure 4: Formation of Aβ Plaques in AD (National Institute of Ageing) 
 
The cleavage of APP plays an important role in formation of amyloid plaques in the brain (Vlassenko, 
2014). (Image from the National Institute on Aging). 
 
Reactive oxygen species (ROS) are chemically reactive compounds containing 
oxygen (Whiteman et. al., 2005). These species include peroxides, superoxides, 
hydroxyl radicals, and singlet oxygen molecules. ROS are a natural product of cellular 
metabolism and have roles in signaling and homeostasis (Espinosa-Diez et. al., 2015). 
However, when environmental stressors trigger large increases in ROS, the cell often 
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cannot respond quickly enough and ROS-induced damage to cellular structures occurs. 
At a high enough level, ROS can induce cell death (Whiteman et. al., 2005).  
 In a normal brain, ROS scavenging enzymes (e.g. glutathione) reduce damage 
from free radicals (Yap, 2006). In an AD brain, ROS is able to overwhelm these repair 
processes (Whiteman et. al., 2005). This excess of ROS damages the mitochondria. In 
turn, because the mitochondria are damaged, they produce more ROS due to the 
inability to fully reduce an oxygen molecule in the last step of oxidative phosphorylation 
due to malfunctioning electron transport chains. This creates a cyclic process that 
generates large amounts of ROS in the cell. In AD brains, molecular oxygen and ROS 
generated by malfunctioning mitochondria are trapped by Aβ plaques. Another enzyme, 
myeloperoxidase (MPO) also co-localizes with Aβ plaques and expression of MPO is 
elevated in neurons of AD brains (Green, 2004). In AD, MPO levels are elevated three-
fold (Whiteman et. al., 2005). MPO converts trapped hydrogen peroxide (a type of ROS) 
to hypochlorous acid, HOCl. Because MPO levels are elevated, and there is a plethora 
of hydrogen peroxide available at plaque sites, HOCl levels are elevated as well, 
causing damage to cellular structures and disrupting metabolic processes. HOCl was 
significantly elevated in AD brain neurons indirectly using a chlorotyrosine biomarker 
only present when HOCl is also present in the cell (Dalle-Donne, 2006). HOCl induces 
apoptotic necrosis in cultured cortical neurons in a dose-dependent fashion (Yap, 2006). 
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Figure 5: MPO Structure and Reaction 
Image created using RasMol and PDB protein ID 5FIW (Human MPO) 
 
MPO converts hydrogen peroxide into HOCl. Both MPO and HOCl levels are elevated in AD. 
 
Antioxidants: scavengers of ROS 
Free Radicals 
 Free radicals are highly reactive unpaired electrons. Reactions with free radicals 
can include the propagation of unpaired electrons to other molecules or reactive species 
(Carocho, 2013). Free radicals can be formed through natural cellular process such as 
mitochondrial metabolism, however, when they react with the wrong substrates they can 
cause damage to cellular structures and processes. There are environmental causes for 
the formation of free radicals as well, including x-rays, pollutants, drugs, pesticides, and 
cigarette smoke. As shown in the above section regarding AD, free radicals play 
important roles in disease states. 
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Figure 6: Mitochondria in healthy vs. ROS-damaged cells 
 
During Alzheimer’s disease, mitochondria near amyloid beta plaques are irreparably damaged by ROS. 
As a result, energy production in the damaged mitochondria falters (Whiteman et. al., 2005). (Image from 
the National Institute on Aging).  
 
These roles extend beyond AD. Radical oxygen species are important in the 
pathology of cancers, Parkinson’s disease, ALS, and general aging processes (Lobo, 
2010). For this reason, many scientists have sought ways to limit damage from free 
radicals and radical oxygen species. 
Antioxidants 
  Antioxidants are compounds that can accept unpaired electrons, and thus 
stabilize radical species (Halliwell, 2008). They act to scavenge reactive radical species 
and thus shield the cell from damage to important cellular processes. Antioxidants act 
by two mechanisms. The first is through directly accepting unpaired electrons. Most 
antioxidant compounds have structures that allow them to remain stable despite 
accepting unpaired electrons (Carocho, 2013). The other method is indirect and 
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operates through inhibiting cellular processes that produce free radicals (Lu et. al., 
2010). Antioxidants are found both in the body, produced through cellular processes, 
and in the food people consume regularly. Diets rich in fruits and vegetables have been 
linked to a decreased risk of getting AD and healthier aging (Pocernich et. al., 2011).  
Ortho-phenols as antioxidants 
 Compounds with antioxidant properties include phenolic molecules that 
scavenge reactive oxygen species and prevent damage to the cell. These compounds 
are primarily derived from catechol, a compound commonly found in plants (Bolton et. 
al., 2017). Catechol-based compounds have a motif of two hydroxyl groups positioned 
ortho to one another on a benzene ring. Compounds like dopamine and caffeic acid 
have similar backbone structures, and are thus considered catechol-based derivatives. 
Figure 7: Examples of common ortho-phenolic catechol-derived antioxidants 
 
Catechol-based ortho phenols all have a benzene ring structure with two hydroxyl groups attached in 
ortho positions. Structures created with ChemDraw. 
In the reactive species scavenging process, catechol-based ortho-phenols can 
be oxidized to ortho-quinones. 
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Figure 8: Oxidation of catechol to an ortho-quinone via tyrosinase 
 
The mushroom tyrosinase enzyme was rendered in RasMol using the PDB file 3NM8. In this reaction, 
catechol is oxidized to benzoquinone. Image created with ChemDraw. 
 
In turn, an ortho-quinone can undergo an irreversible Michael addition with thiol groups 
in the cell, including cysteine residues in proteins.  
Figure 9: Cysteine modification by an ortho-quinone via Michael addition 
 
An available cysteine on a protein can react easily with most ortho-quinones. The thiol group acts as a 
nucleophile and in the reaction process the quinone is reduced back to a phenol. Image created with 
ChemDraw. 
 
This demonstrates the possibility for a compound with antioxidant properties to be 
converted into a pro-oxidant that can potentially damage proteins by binding to cysteine 
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residues. By modifying cysteine residues, ortho-quinones could disrupt both protein 
structure and function. 
Energy production in disease states 
Anaerobic Glycolysis 
 Reactive oxygen species in AD and cancers target mitochondrial respiration. To 
combat and prevent further damage to the mitochondria, diseased cells often 
upregulate glycolysis, a process that occurs in the cytosol of the cell, thus allowing for 
energy production without requiring functional mitochondrial respiration (Kim, 2005). 
Glycolysis consists of ten reactions that ultimately convert glucose to pyruvate and 
generate two net ATP molecules per each pyruvate produced from glucose. This is 
significantly less energy than the 32 molecules of ATP generated in mitochondrial 
respiration. Thus, to compensate for a loss of mitochondrial respiration, glycolysis must 
be significantly upregulated. When oxygen is not available (e.g. in tumor conditions), or 
the electron transport chain is malfunctioning, the cell may undergo lactic acid 
fermentation – the process by which energy is generated without the use of oxygen, 
also called anaerobic glycolysis. The upregulation of anaerobic glycolysis has been 
noted in cancers and in AD.  
Recently, glycolytic enzymes have been implicated in pathways other than 
glycolysis (Kim, 2005). PK, LDH, GAPDH, and ENO1 all have dual roles as transcription 
factors. This recently discovered link between metabolic functions in the cytosol and 
transcription modifications in the nucleus demonstrate why it is important to continue to 
study glycolytic enzymes. 
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Lactate dehydrogenase (LDH) structure and function 
 LDH is responsible for conversion of pyruvate to lactate during anaerobic 
glycolysis (Kim, 2005). It facilitates the oxidation of the cofactor NADH to replenish 
NAD+. This process is key in disease states that depend on anaerobic glycolysis – 
without LDH and lactic acid fermentation, glycolysis would be unable to continue 
because NAD+ resources would deplete. 
Figure 10: Lactate dehydrogenase replenishes NAD+ in anaerobic glycolysis 
 
Anaerobic glycolysis, or lactic acid fermentation. Image created with ChemDraw. 
 
LDH is composed of 4 subunits, each with catalytic capabilities (Diaz, 1993). One 
subunit has a mass of 36 kDa. Muscle LDH is encoded by the LDH-A gene. There is 
also an LDH-B gene that produces heart muscle LDH. A conserved catalytic histidine in 
the active site of the enzyme (histidine 192 in rabbit muscle LDH) helps to bind pyruvate 
following formation of the LDH/NADH complex (McClendon, 2005). If this histidine is 
modified before substrate binding, activity of the enzyme is greatly reduced. Arginine 
109 (Arg111 in rabbit muscle LDH) plays an important role in solvating the carboxylic 
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acid group of the pyruvate and is part of approximately 10 amino acids that closes over 
pyruvate to secure its binding. Internally, LDH is highly hydrophobic and has an 
isoelectric point of 8.4. 
Figure 11: Rabbit muscle LDH structure 
 
Arginine 111 is in blue, histidine 192 is in magenta, cysteine residues are in green, and internal 
hydrophobic regions are highlighted in yellow. This image is directed into the open active site of LDH. 
Image created using RasMol and PDB file 3H3F. 
  
LDH may also play important roles in other cellular functions (Kim, 2005). Lactate 
is an intercellular messenger, recruiting metabolic resources from astrocytes 
(Vlassenko, 2014). LDH also can act as a transcription factor such that when it is bound 
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to DNA it enables the transcription of genes related to synaptic plasticity. LDH also has 
been implicated in other signaling mechanisms, including contributing to DNA helix 
destabilization (Kim, 2005). Because of LDH’s many roles in the cell and its important 
role in energy production in disease states, studying LDH and its reaction to oxidative 
stress is imperative for furthering the understanding of disease mechanisms, and 
understanding the potential implications of damaged glycolytic enzymes on other 
aspects of cellular functions. 
Protein thiol chemistry 
Redox homeostasis 
 Endogenous thiols help to maintain redox homeostasis in cells (Lushchak, 2012). 
Low molecular weight thiols are ubiquitous in cells and include molecules like 
glutathione (GSH). These thiols scavenge reactive oxygen species, indirectly protecting 
proteins and other structures from damage. Thiols like glutathione can also interfere 
with protein structure and function by forming disulfide bridges with cysteine residues. 
Thus, it is important to maintain the right balance of free thiols in the cell such that they 
protect against free radical damage, but do not also disrupt cellular function. Glutathione 
is the most abundant free thiol in eukaryotic cells (Poole, 2015). 
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Figure 12: Glutathione structure 
 
GSH is a common, highly abundant, substrate used for scavenging reactive oxygen species in cells. It 
also is used to maintain redox homeostasis in cells. Image created with ChemDraw. 
  
Enzymes like superoxide dismutases scavenge radicals by converting 
superoxide anions to hydrogen peroxide and molecular oxygen. Enzymes like catalase, 
glutathione peroxidase, and peroxiredoxin then scavenge the hydrogen peroxide 
(Lushchak, 2012). Glutathione is used as a substrate for many of these reactions, and is 
thus found at concentrations ranging from 2 mM – 10 mM in the cytosol, mitochondria, 
nucleus, and endoplasmic reticulum. 
Cysteine residues 
 Cysteine residues contain reactive thiols that often play key roles in protein 
structure and function; however, because of the reactive nature of cysteine residues, 
they are also often targets of oxidative stress and free radical damage (Giles et. al., 
2003).  
 
 
21 
 
 
Figure 13: Cysteine amino acid structure 
 
Cysteine is one of the twenty naturally occurring amino acids. Image created with ChemDraw. 
 
Cysteine residues are highly nucleophilic both as S- and as SH. They are also 
highly redox active with low redox potentials – this allows them to function as electron 
donors and facilitate electron transfer. Cysteine residues also can bind metals, as seen 
in alcohol dehydrogenase (ADH) where cysteine residues bind two catalytic zinc atoms. 
Thus, cysteine residues have the ideal properties to play important roles in catalysis in 
many proteins (Poole, 2015). It is important to study cysteine chemistry to further 
understand the role of cysteine residues in various enzymes and how different 
modifications of cysteine residues can affect enzyme function. 
Thiol reactions investigated for this paper 
HOCl, a relevant reactive oxygen species found in AD can react with cysteine 
residues in proteins to produce thiosulfinate, disulfides, and sulfenic acid (Hillion, 2015). 
Glutathione can both scavenge reactive oxygen species as well as bind directly to 
proteins or initiate disulfide bonds between two proteins. Ortho-quinones can covalently 
bond to cysteine residues via Michael addition. 
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Figure 14: LDH cysteine reactions with HOCl, GSH, and ortho-quinones 
 
Image created with ChemDraw Ultra. 
 
These are the reactions that will primarily be investigated in this paper. 
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Materials and Methodology 
Materials 
Purified proteins and cellular extracts: 
Lactate dehydrogenase (LDH) from rabbit muscle (36,000 g/mol per subunit), 
alcohol dehydrogenase (ADH) from yeast (146,800 g/mol), and tyrosinase from 
mushroom were obtained from Sigma-Aldrich. Chicken muscle extract, chicken liver 
extract, and beef liver extract were produced from tissue samples obtained 
commercially. Yeast cell extract was produced from lysed yeast cells grown in lab by Dr. 
Lisa Landino. 
Compounds: 
HOCl, 5-(Iodoacetamido)fluorescein (IAF), 200 proof lab grade ethanol (EtOH), 
(tris(2-carboxyethyl)phosphine) (TCEP), nicotinamide adenine dinucleotide (NAD+), 
nicotinamide adenine dinucleotide + hydrogen (NADH), sodium pyruvate, catechol, 
PP60 tea extract, glutathione (GSH), and N-ethylmaleimide (NEM) were obtained from 
Sigma-Aldrich. Caffeic acid was obtained from Acros Organics. Ammonium persulfate 
and TEMED were obtained from Fisher Scientific. 
Tea phenolic antioxidants were extracted in boiling water from Sigma Aldrich 
PP60 Green Tea Extract, Trader Joe’s Organic Green Tea, Yogi Green Tea Kombucha, 
Clipper Rise & Shine, and Guayaki Yerba Mate Organic. Hops phenolic antioxidants 
were extracted from YCHHOPS German Hallertau hop pellets, YCHHOPS United 
States Cascade hop pellets, and LD Carlson’s Apollo Hop Pellets.  
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Methods 
For this research we conducted three major assays: an LDH kinetics assay using 
UV/Vis spectroscopy, an ADH kinetics assay using UV/Vis spectroscopy, and SDS-
PAGE using oxidized LDH samples labeled with IAF. 
Protein purification: 
LDH from rabbit muscle was obtained in a suspension with 3.2 M ammonium 
sulfate (pH 7). Using a desalting column (Econo-Pac 10DG columns from Bio-Rad 
Laboratories in Munich, Germany) and buffer solution, the salt impurities in the original 
LDH suspension were removed. The concentrations of the purified LDH solutions were 
determined using UV/Vis spectroscopy and Beer’s Law. Beer’s Law relates Absorption 
(𝐴) to the concentration of the sample in the following way: 
𝐴 = 𝜀 ∗ 𝑏 ∗ 𝑐 
where 𝜀 is the extinction coefficient unique to the protein, 𝑏 is the path length that the 
light travels through the sample, and 𝑐 is the concentration of the protein in the sample 
(Powers et al., 2007). Absorption was read at 280 nm. The extinction coefficient for LDH 
is 176,220 cm-1M-1 (for one tetramer). The path length of the BioTek Intruments 
(Highland Park, Winooski, VT) microplate reader for the 96-well plate samples is 0.6 cm 
based on numerous calculations in lab. 
ADH from yeast extract was obtained as a lyophilized powder. Using a desalting 
column, buffer salt impurities were removed. Purified ADH concentrations were 
determined using UV/Vis spectroscopy and Beer’s Law. Absorption was read at 280 
nm. The extinction coefficient for ADH is 189,320 cm-1M-1. 
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Preparation of chicken muscle, chicken liver, and beef liver extracts: 
 25 g of chicken muscle (or chicken liver or beef liver) was chopped into fine 
pieces, and suspended in 3 volumes (75 mL) of cold LDH extraction buffer composed of 
20 mM Tris-HCl (pH 8.6) containing 1 mM DTT (a disulfide reducing agent). Tissue 
samples were then homogenized in a Waring blender for 2 minutes. Proteins were 
extracted by stirring for 1 hour at 4℃. The extract was centrifuged at 10,000 rpm for 45 
minutes, prior to decanting the supernatant into a clean centrifuge tube. The 
supernatant was then centrifuged for the same time and speed. The final supernatant 
obtained after centrifuging was the final “extract.” 
Preparation of tea and hops extracts: 
 One gram (or close to – see Appendix 3 for specific values) of each tea sample 
and each hops sample was dissolved separately in 100 mL of DI water and boiled for 30 
minutes. The mixtures were filtered into sterile 50 mL test tubes. Aliquots from these 50 
mL tubes were added to 1.5 mL centrifuge tubes and centrifuged for 15 minutes at 
10,000 rpm. The supernatant was removed and added to new 1.5 mL tubes and these 
tubes were frozen at -20℃. 
Oxidation of LDH and ADH samples: 
2.36 mg/mL (65.2 µM tetramer) LDH in 10 mM phosphate buffer (pH 7.4) and 
2.43 mg/mL (66.21 µM tetramer) ADH in 10mM phosphate buffer (pH 7.4) were stored 
at -80℃. After thawing, 2.29 µL and 1.5 µL of the respective LDH and ADH solutions 
were added to separate 0.5 mL microfuge tubes. Next, 10 mM phosphate buffer (pH 
7.4) was added to the microfuge tubes in the desired amount, leaving room for an 
oxidizing agent or other modifying compound (eventually giving a total volume of 15 µL 
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in the microfuge tube). Next, 1.5 µL of a desired concentration of an oxidizing agent 
(HOCl, caffeic acid, catechol, PP60, tea extract, or hops extract) was added to each 
microfuge tube. All of these oxidants were diluted in warm DI water with the exception of 
caffeic acid which was initially diluted in DMF, but can also be diluted in hot DI water). 
Lastly, 2.0 µL of 0.5 mg/mL tyrosinase was added if required (to catalyze the transition 
between ortho-phenolic compounds and ortho-quinones). The final concentration of 
cysteine amino acids in the microfuge tubes was 50 µM. Samples were incubated at 
37℃ for 30 minutes. 
Modifications of oxidation process: 
Following sample incubation at 37℃, 2.0 µL of 5.0 mM TCEP (a reducing agent) 
could be added to the samples to determine if any oxidation damage could be reversed. 
Control samples received 2.0 µL of DI water. Samples were incubated a second time, 
for 5 minutes. 
Prior to incubation (included in 15 µL of total sample volume) and to oxidant 
addition, glutathione dissolved in DI water could be added to the LDH and ADH 
samples. The samples were then incubated for the usual 30 minutes at 37℃.  
For assays involving pH variation, the samples were prepared in 10 mM 
phosphate buffer (pH 6.0, 6.4, 6.9, 7.4, and 8.0). 
LDH kinetics procedure: 
Using a BioTek Instruments microplate-reader, transparent Corning 96-well 
plates, and Gen5 Version 1.11 (2005 BioTek Intruments) UV/Vis analysis software, LDH 
activity was determined based on the oxidation of NADH (absorbance at 340 nm) to 
NAD+ (no absorbance at 340 nm). 
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First, following incubation, the oxidized LDH was diluted 1:50 in 10 mM 
phosphate buffer (pH 7.4 unless pH variation was being tested in which case the pH of 
the dilution matched the pH of the initial sample). 
Then, in a 96-well plate, the following was prepared: 
 Column 1: Blank Column 2: 
Assay Control 
Column 3: 
Sample #1 
Column 4-12: 
Samples #2-
10 
Row A 200 µL 10 mM Tris 
buffer (pH 7.4) 
190 µL 10 mM 
Tris buffer (pH 
7.4) 
 
10 µL 10mM 
NADH 
160 µL 10 mM 
Tris buffer (pH 
7.4) 
 
15 µL 10 mM 
pyruvate 
 
15 µL of 1:50 
diluted sample 
#1 
 
10 µL 10 mM 
NADH 
160 µL 10 mM 
Tris buffer (pH 
7.4) 
 
15 µL 10 mM 
pyruvate 
 
15 µL of 1:50 
diluted sample 
N 
 
10 µL 10 mM 
NADH 
  
 After the addition of the NADH, the individual wells were mixed three times 
quickly with a 200 µL pipette and the plate inserted into the reader. The reader was kept 
at 37℃. Absorbance of NADH was read every 30 seconds for 5 minutes at 340 nm. 
Using Beer’s Law and linear regression, a rate in mM NADH/min/mg LDH could be 
determined. The extinction coefficient for NADH is 6220 M-1cm-1 (Bergenmeyer, 1975). 
The calculated pathlength was 0.6 cm. 
ADH kinetics procedure: 
Using a BioTek Instruments microplate-reader, transparent Corning 96-well 
plates, and Gen5 Version 1.11 (2005 BioTek Intruments) UV/Vis analysis software, 
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ADH activity was determined based on the reduction of NAD+ (no absorbance at 340 
nm) to NADH (absorbance at 340 nm). 
First, following incubation, the oxidized ADH was diluted 1:50 in 10 mM 
phosphate buffer (pH 7.4 unless pH variation was being tested in which case the pH of 
the dilution matched the pH of the initial sample). 
Then, in a 96-well plate, the following was prepared: 
 Column 1: Blank Column 2: 
Assay Control 
Column 3: 
Sample #1 
Column 4-12: 
Samples #2-
10 
Row A 200 µL 20 mM Tris 
buffer (pH 8.8) 
185 µL 20 mM 
Tris buffer (pH 
8.8) 
 
10 µL 10 mM 
NAD+ 
155 µL 20 mM 
Tris buffer (pH 
8.8) 
 
15 µL 1 M 
EtOH 
 
15 µL of 1:50 
diluted sample 
1 
 
15 µL 10 mM 
NAD+ 
155 µL 20 mM 
Tris buffer (pH 
8.8) 
 
15uL 1 M 
EtOH 
 
15 µL of 1:50 
diluted sample 
N 
 
15 µL 10 mM 
NAD+ 
 
After the addition of the NAD+, the individual wells were mixed and the plate 
inserted into the reader. The reader was kept at 37℃. Absorbance of NADH was read 
every 30 seconds for 5 minutes at 340 nm. Using Beer’s Law and linear regression, a 
rate in mM NADH/min/mg ADH could be determined. 
IAF labeling procedure and SDS-PAGE 
 Following sample incubation for 30 minutes, 2 µL of 5.0 mM IAF was added to 
each sample. Samples were incubated for an additional 30 minutes. During sample 
incubation, a 10% separating gel was prepared using Mini-PROTEAN Tetra Cell 
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supplies (from Bio-Rad Laboratories in Munich, Germany), 4.0 mL of DI water, 3.33 mL 
of 30% acrylamide, and 2.5 mL of 1.5 M Tris Buffer (pH 8.8). After mixing, the solution 
was degassed for 5 minutes under vacuum. Next, 100 µL of 10% SDS and 50 µL of 
10% ammonium persulfate were added to the solution. ~15 µL of TEMED initiated gel 
polymerization in approximately 20-30 minutes.  
 After the separating gel polymerized, a stacking gel was prepared using 1.5 mL 
of DI water, 0.335 mL of 30% acrylamide, 0.625 mL of 0.5 M Tris buffer (pH 6.8), 50 µL 
of 10% SDS, 50 µL of saturated ammonium persulfate, and 5 µL of TEMED. The 
stacking gel was layered on the separating gel and polymerized in approximately 20 
minutes. Well combs were removed and wells were rinsed.  
 After samples incubated with IAF, sample buffer (+ BME) was added to each 
sample test tube. Samples were loaded into wells. Gels were run for approximately 1.5 
hours at 90 volts. After electrophoresis was complete, gels were removed and imaged 
using a ChemiDoc XRS+ Imaging System (from Bio-Rad Laboratories in Munich, 
Germany). 
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RESULTS AND DISCUSSION 
Rabbit muscle LDH kinetics  
First, Vmax and Km values for the rabbit muscle LDH used in lab were 
determined by varying concentrations of pyruvate (substrate) while maintaining known 
concentrations of NADH (cofactor) and LDH. Reactions were run using the LDH kinetics 
procedure outlined in the methodology section; however, pyruvate concentrations 
ranged from ~0.05 mM to ~2.00 mM. The following Michaelis Menten fit was produced 
using OriginPro 2016 analysis software. 
Figure 14: Michalis Menten Approximation for LDH Kinetic Activity 
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To establish this curve, a linear fit was applied to the initial reaction rates for LDH at each pyruvate 
concentration. The linear fits were determined across three trials and averaged (the error bars are very 
small, but present on the graph). Next, a Michalies Menten curve fit was applied to the data using 
OriginPro 2016. Based on R values nearly equal to 1, the curve fit was satisfactory and Vmax and Km 
values for rabbit muscle LDH were reported. 
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 The fit indicates a Vmax value of 13.2 mM NADH consumed per minute per 
milligram of LDH. The Km concentration was determined to be 0.8 mM of pyruvate. 
These values matched expected literature Vmax and Km values for rabbit muscle LDH 
(Hess, 1970). This information indicated that further experimentation on the rabbit 
muscle LDH enzyme could be done with confidence that the enzyme behaved as 
expected in vitro. 
Rabbit muscle LDH and HOCl 
 Because of the relevance of hypochlorous acid (HOCl) in Alzheimer’s disease, 
LDH was exposed to varying concentrations of HOCl to determine whether HOCl 
decreased LDH activity and modified cysteine residues on the protein. HOCl 
modification of LDH was then compared with modification of LDH by N-ethylmaleimide 
(NEM), a known thiol group modifier (Alexander, 1958).  
Figure 15: Inhibition of rabbit muscle LDH with HOCl 
 
For each HOCl concentration, LDH was incubated with the oxidant for 30 minutes. The results were 
compared to a control sample without HOCl. The results were averaged over six trials. 
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 Addition of HOCl at each concentration decreased LDH activity significantly 
(p<0.05) compared with the control (using a one-way ANOVA test via OriginPro 2016). 
To determine if this decrease in activity correlated with cysteine modification, HOCl first 
was added to LDH samples. Then, after incubation, IAF was added. If the HOCl 
successfully modified the cysteine residues in LDH, we expected to see decreased 
labeling with IAF as HOCl concentrations increased, and did indeed observe these 
expected results. 
Figure 16: IAF labeling of rabbit muscle LDH after HOCl addition 
 
Shown above is an inverted image. As HOCl concentrations increase, the fluorescence of the gel bands 
decreases. Because IAF modifies cysteine residues, we can confirm that as HOCl is added in increasing 
amounts to LDH, IAF molecules are unable to access as many cysteine residues. 
  
To compare these results with a known cysteine modifier, varying concentrations 
of NEM were reacted with LDH causing a clear decline in enzyme activity, and IAF 
labeling confirmed that NEM modified LDH cysteine residues. 
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Figure 17: Inhibition of rabbit muscle LDH with NEM; IAF labeling of LDH after 
NEM addition 
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Using OriginPro 2016, a dose-response logarithmic curve was established for LDH inhibition with NEM. 
NEM inhibits LDH across the range of concentrations shown on the gel and IAF labeling of cysteine 
residues decreases as NEM concentration increases. 
  
In conclusion, addition of HOCl at concentrations as low as 25 µM to 50 µM 
samples of LDH inhibited LDH activity and modified cysteine residues on the protein or 
changed protein conformation such that IAF could not label all of the LDH cysteine 
residues. Additional analysis of tryptophan fluorescence in LDH shows that as HOCl is 
added to LDH samples, tryptophan fluorescence changes. There is a tryptophan at 
position 187 in rabbit muscle LDH (using the PDB 3H3F file) which is very close to a 
cysteine residue at position 184. If Cys184 is modified by HOCl and conformation 
around that residue changes, there could be significant changes in the nearby 
tryptophan fluorescence.  
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Figure 18: Tryptophan (W) fluorescence in rabbit muscle LDH with addition 
of HOCl 
 
As HOCl was added to LDH samples, the tryptophan fluorescence at 340 nm changed in intensity. At low 
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fluorescence increased. At higher concentrations of HOCl (100-500 µM), the tryptophan fluorescence 
intensity decreased.  
  
Based on the results of the tryptophan fluorescence and the proximity of 
tryptophan 187 to cysteine 184, there are likely conformational changes that occur when 
LDH is exposed to concentrations of HOCl ranging from 10 µM to 500 µM. This further 
substantiates the claim that HOCl does modify cysteine residues on LDH since the 
fluorescence behavior of tryptophan 187 changes so significantly. Most likely, the 
environment around the tryptophan is changing as protein conformational shifts occur. 
This aspect of the project needs more investigation, and will be addressed further in 
subsequent months. 
Protection of LDH from HOCl damage 
 Following confirmation that HOCl inhibits rabbit muscle LDH, NAD+ was used to 
attempt to protect the protein from HOCl damage. NAD+ was initially added to LDH. This 
solution was incubated for 5 minutes at 37℃. Then HOCl was added and the samples 
were incubated for the usual 30 minutes.  
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Figure 19: Protection of rabbit muscle LDH from HOCl oxidation by NAD+ 
 
“C1” is the LDH control (-NAD+, -HOCl). When NAD+ is bound to rabbit muscle LDH prior to addition of 
HOCl, less damage occurs than predicted by HOCl addition with no protection. IAF labeling of cysteine 
residues remains intense (dark) when HOCl is added if NAD+ is first bound to the rabbit muscle LDH. HOCl 
does not react with NAD+ or NADH. 
  
While protection with NAD+ and NADH successfully prevented activity decline, 
pyruvate did not have the same preventative effects. We attributed this to pyruvate’s 
smaller size relative to NAD+/NADH, as well as that the binding site for pyruvate is 
slightly different from the binding site for NAD+/NADH. Since NAD+/NADH is large, when 
it is bound it could be more effective at shielding the active site and internal cysteine 
residues from oxidative damage than pyruvate. In the case of LDH activity, NADH 
binding precedes substrate binding (Deng, 2001). Once NADH binds to LDH, the loop 
that facilitates binding of pyruvate is able to open and allow the substrate to fit into the 
active site (Pineda, 2007).  
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Reduction of oxidized LDH with TCEP 
 TCEP, a common reducing agent used in biochemical applications, was used to 
attempt to restore activity to HOCl-oxidized rabbit muscle LDH. LDH that had been 
incubated with HOCl for 30 minutes was exposed to 2.0 µL of 5 mM TCEP (for a 
concentration of ~600 µM in the microfuge tube samples). This reaction was incubated 
for an additional 15, 30, and 45 minutes. While activity was not restored significantly, 
IAF labeling did increase. 
Figure 20: Reduction of oxidized LDH with TCEP; activity and IAF labeling 
 
TCEP did not restore much activity to the rabbit muscle LDH; however, IAF bands appear to be darker 
when TCEP is added to the oxidized LDH sample. All experiments were performed three times and 
averaged. 
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Oxidation of LDH with HOCl in chicken and beef liver extracts 
 To determine if LDH could be oxidized with HOCl in the context of a cellular 
extract, we exposed chicken and beef liver extracts to 100 µM of HOCl and ran the 
usual LDH kinetics procedure on the samples. 
Figure 21: LDH activity and HOCl modification of LDH in Beef liver and chicken 
liver extracts 
 
LDH activity was present in both the beef (BL) and chicken liver (CL) extracts. At 100 µM of HOCl, 
inhibition of LDH activity could be seen clearly in the beef liver extract. There was no significant change in 
LDH activity in the chicken liver extract. 
  
Beef liver extract LDH showed a decrease in activity at 100 µM HOCl, but 
chicken liver LDH did not (even when higher concentrations of HOCl were added). This 
could be due to the abundance of other proteins that were reacting with the HOCl or 
scavengers in the extract – because of the desalting column, GSH and other small 
molecule thiols were removed.  
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Oxidation of LDH and ADH with ortho-quinones 
 To understand the extent to which oxidized catechol-based derivatives could 
modify LDH and change the protein’s activity, phenolic compounds including catechol 
and caffeic acid, were oxidized to quinones using mushroom tyrosinase (E). The 
quinones were then added to solutions of LDH. First, catechol, a compound found in all 
plants was oxidized to its corresponding quinone and tested with LDH. We chose to 
compare our results to those using ADH from yeast, another protein with essential 
cysteine residues. 
Figure 21: Oxidation of rabbit muscle LDH and yeast ADH with oxidized catechol 
(benzoquinone) 
 
ADH and LDH assays were performed according to the procedures outlined in the methodology section. 
“E” refers to the tyrosinase enzyme. Shown above are averages across three trials. 
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 Benzoquinone inhibits LDH and ADH activity starting at concentrations as low as 
25 µM. Catechol does not. These results matched expectations since the mechanism 
for oxidation of protein cysteine residue by quinones follows a Michael addition, and 
thus the carbonyls on the conjugated ring are important for reaction with thiol groups on 
proteins (Bolton, 2017). Oxidized caffeic acid had similar effects on LDH and ADH 
activity. 
Figure 22: Oxidation of rabbit muscle LDH and yeast ADH with oxidized caffeic 
acid 
 
 
ADH and LDH assays were performed according to the procedures outlined in the methodology section. 
“E” refers to the tyrosinase enzyme. Shown above are averages across three trials. 
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 These results lead us to test oxidized catechol and caffeic acid on LDH and ADH 
in cell extracts. Chicken muscle extract was used to test for LDH inhibition with caffeic 
acid, and yeast cell extract was used to test for ADH inhibition. There was little to no 
effect on the LDH in the chicken extract, likely due to the many proteins that could have 
been oxidized instead of LDH. However, was a decrease in ADH activity using the yeast 
extract. 
Figure 23: Oxidation of ADH in yeast extract using oxidized caffeic acid 
 
Yeast extract assays were performed according to the procedures outlined in the methodology section. 
“E” refers to the tyrosinase enzyme. “YE” refers to “Yeast Extract.” Data summaries shown above are 
averages across three trials. 
  
While it is clear that tyrosinase-oxidized caffeic acid significantly depleted ADH 
activity in the yeast extract samples, the control non-oxidized caffeic acid samples also 
showed decreased activity. This could be due to other processes occurring in the yeast 
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no tyrosinase, more inhibition of ADH activity could be seen, giving some credence to 
this theory. 
 After examining the effects of oxidized catechol and caffeic acid on LDH and 
ADH activity, other phenolic derivatives were tested. This included oxidized dopamine, 
oxidized morin, oxidized alizarin, etc. (see Appendix 3). These compounds were 
selected to test the limit of how sterically hindering a compound could be before it no 
longer bound to LDH or ADH to inhibit activity, as well as how diverse the conjugated 
ring could be in terms of number of hydroxyl groups and location. The results of these 
studies are summarized in Appendix 3. We determined that many compounds larger 
than dopamine were not as potent, and compounds with more than two hydroxyl groups 
also did not inhibit the enzymes as well although this feature mattered less than size.  
 After looking at individual compounds, extracts from various teas and hops were 
tested for inhibitory properties. PP60 tea extract was purchased and tested first since it 
has known components.  
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Figure 24: Oxidation of rabbit muscle LDH and yeast ADH with oxidized phenolic 
compounds in PP60 green tea extract 
 
 
ADH and LDH assays were performed according to the procedures outlined in the methodology section. 
“E” refers to the tyrosinase enzyme. The PP60 extract was diluted to 1 mg/mL and 2 mg/mL in DI water. 
1.5 µL of these solutions were added to each sample of protein and then incubated. Shown above are 
averages across three trials. The extract contains 60% catechin, 34% (-)-epigallocatechin-3-gallate, 
16.7% (-)-epigallocatechin, 8.7% (-)-epicatechin-3-gallate, 7.3% (-)-epicatechin, 2.8% (-)-gallocatechin 
gallate, and 0.5% (-)-catechin gallate, tannic acid, or (-)-epigallocatechin-3-gallate. 
 
Once it was determined that PP60 green tea extract inhibited LDH and ADH 
activity, extracts were obtained from four different teas (two green, two herbal), and 
three hops varieties. LDH and ADH were exposed to these extracts using the standard 
oxidation process outlined in the methodology section. The most significant effects 
occurred with LDH. 
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Figure 25: Oxidation of rabbit muscle LDH with oxidized phenolic compounds in 
tea extracts and hops extracts 
 
The tea extracts were from (left to right): Trader Joe’s Organic Green Tea, Yogi’s Green Tea Kombucha, 
Clipper’s Rise and Shine Herbal Tea, and Guayaki Herba Mate Herbal Tea. The hops extracts were from 
(left to right) YCHHOPS German Hallertau, YCHHOPS United States Cascade, and LD Carlson’s Apollo 
hops pellets. A 1:10 dilution of the extracts was made and both the dilution and raw extracts were tested 
with LDH. “E” stands for “tyrosinase enzyme.”  
  
The tea and hops extracts that were combined with tyrosinase all inhibited LDH 
activity. There was, however, a difference between the herbal teas and the green teas. 
The green teas clearly inhibited LDH activity with and without the tyrosinase addition, 
behaving like the PP60 green tea extract. The herbal teas only inhibited LDH with the 
addition of tyrosinase. The hops extracts behaved this way as well. Our lab still needs to 
perform LC/MS on the extracts to determine their exact compositions, but we know that 
these extracts contain at least catechol since catechol is an essential component of all 
plant cell walls. 
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Glutathione competition with oxidants 
 Glutathione (GSH) was added to ADH and LDH samples prior to addition of 
HOCl and caffeic acid. The samples were incubated for the usual 30 minutes. Results 
indicated that for both ADH and LDH (and for both oxidants), GSH at concentrations 
ranging from 2 mM to 10 mM successfully scavenged oxidants at 100 µM. There was no 
change between the control LDH/ADH samples and the samples exposed to HOCl after 
being combined with GSH. These results suggest that at reasonable cellular levels of 
GSH, both HOCl and caffeic acid can be scavenged, and damage to LDH and ADH can 
be prevented. Despite this test, actual cellular contexts are much more complex and it is 
still reasonable to assume that in the case of bursts of high levels of oxidative stress in 
disease states, LDH could be overwhelmed regardless of GSH presence. 
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CONCLUSION 
 This research shows that LDH is inhibited by low concentrations of HOCl and 
catechol-based ortho-quinones. Evidence from this research and other research in Dr. 
Landino’s lab strongly suggests that cysteine residues on LDH are modified in the 
process of oxidation. Thus, in a disease context like Alzheimer’s, high levels of HOCl 
generated near plaques by MPO is likely enough to severely hinder LDH viability in 
nearby neurons, and could contribute to irreparable energy loss in those regions. Since 
plaques can be present in the brain 10-15 years before the onset of symptoms, it is 
possible that HOCl damage to energy production in neurons occurs early as well.  
 The results of this research also suggest that not all antioxidants are always 
effective at preventing oxidative damage, and can actually contribute to damage in 
states of high oxidative stress. Compounds like catechol and caffeic acid are abundant 
in foods and it is possible for them to be oxidized in the body after consumption. The 
resulting ortho-quinones can modify cysteine residues on important enzymes involved in 
energy production, like LDH. While these results are intriguing, there are still several 
more questions that need to be investigated. Namely, if these compounds do in fact 
modify cysteine residues on LDH and ADH in vitro, can we replicate this in vivo? 
Currently, Dr. Lisa Landino’s lab at the College of William and Mary in Virginia is 
attempting to show that ADH is modified within yeast cells when exposed to these 
compounds. The lab is working on developing effective assays that can accurately 
determine if the compounds are bound to cysteine residues on a protein when using 
whole-cells or cell lysate.  
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 Additionally, it would be useful to do circular dichroism on LDH and ADH when 
they are exposed to these various oxidative compounds to determine more closely what 
specific conformation changes are occurring within the protein, and how each individual 
cysteine responds to its surrounding environment. More fluorescence data could also 
help determine how many cysteine residues are consistently modified by the various 
oxidizing agents. Lastly, it would also be useful to continue to expand the compounds 
used in the oxidizing process so that characterization of LDH and ADH responses can 
be more complete and extensive. See Appendix 3 for the full list of compounds and 
results regarding all oxidative agents used. 
 This research, and other research that is focused on glycolytic enzymes in the 
context of disease states is useful because it represents a type of basic research that 
has not been explored until recently and the results of which will contribute to 
understanding currently uncured diseases. In addition, studying the benefits and 
potential harms of antioxidants is relevant with respect to the current attention given to 
antioxidants as compounds that prevent the symptoms of ageing. Ageing and age-
related diseases are not well understood. Research that addresses the basic underlying 
mechanisms of cell death in these contexts is needed to further understand how our 
body works in states of stress and redox instability. 
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APPENDIX 
Table of frequently used compounds, their structures, and abbreviations 
Compound Structure Abbreviation 
Hypocholorous acid 
(bleach) 
 
HOCl 
Nicotinamide adenine 
dinucleotide 
 
NADH (NAD+) 
tris(2-
carboxyethyl)phosphine 
 
TCEP 
5-
(Iodoacetamido)fluorescein 
 
IAF 
N-ethylmaleimide  
 
 
NEM 
Catechol 
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Caffeic Acid 
 
CA 
Glutathione 
 
GSH 
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Yeast ADH structure with labeled important amino acids (PDB file 4W6Z) 
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All phenolic compounds oxidized and tested for inhibition properties with LDH 
and ADH 
Compound Structure Compound 
Name and 
Information 
LDH (% 
inhibition with 
and without 
tyrosinase “E”) 
ADH (% 
inhibition with 
and without 
tyrosinase “E”) 
 
catechol 
MW = 110.11 
Solubility: 430 
g/L H2O 
LDH assay 
Without E: 
100uM → 0 +/- 
5% 
With E: 
100uM → 80 +/- 
15% 
ADH assay 
Without E: 
100uM → 0 +/- 
10% 
With E: 
100uM → 100 
+/- 2% 
 
  
1,4-
dihydroxybenze
ne 
(hydroquinone) 
MW = 110.11 
Solubility: 6.72 
g/L H2O 
LDH assay: 
Without E: 
100 uM → 10 
+/- 10% 
With E: 
100uM → 5 +/- 
10% 
ADH assay 
Without E: 
100uM → 0 +/- 
10% 
With E: 
100uM → 100 
+/- 2% 
 
hydrocaffeic 
acid 
MW = 182.18 
Solubility: 428 
mg/mL H2O 
 
LDH assay: 
Without E: 
100uM → 30 +/- 
10% 
With E: 
100uM → 80 +/- 
10% 
ADH assay 
Without E: 
100uM → 0 +/- 
10% 
With E: 
100uM → 100 
+/- 2% 
 
caffeic acid 
MW = 180.18 
CAS 331-39-5 
7 mg/mL DMF 
LDH assay: 
Without E: 
100uM → 20 +/- 
10% 
With E: 
100uM → 75 +/- 
10% 
ADH assay 
Without E: 
100uM → 0 +/- 
0.1% 
With E: 
100uM → 100 
+/- 0.1% 
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L-dopa                
MW = 197.19 
Solubility: 5 
mg/mL H2O 
LDH assay: 
Without E: 
100 uM → 5 +/- 
10% 
With E: 
100uM → 25 +/- 
2% 
ADH assay 
Without E: 
100uM → 0 +/- 
5% 
With E: 
100uM → 70 +/- 
5% 
 
L-tyrosine 
MW = 181.19 
Solubility: .453 
mg/mL H2O 
 
Unable to 
dissolve 
ADH assay 
Without E: 
100uM → 0 +/- 
10% 
With E: 
100uM → 80 +/- 
0.5% 
 
 
quercetin 
MW = 302.236 
we have 
dihydrate 
so MW = 338.28 
Solubility: 30 
mg/mL DMF 
LDH assay: 
Without E: 
100uM → 30 +/- 
5% 
With E: 
100uM → 35 +/- 
5% 
ADH assay 
Without E: 
100uM → 0 +/- 
5% 
With E: 
100uM → 0 +/- 
2% 
 
 
morin 
MW = 302.236 
Solubility: 50 
mg/mL DMF 
LDH assay: 
Without E: 
100uM → 10 +/- 
5% 
With E: 
100uM → 60 +/- 
5% 
 
ADH assay 
Without E: 
100uM → 5 +/- 
5% 
With E: 
100uM → 20 +/- 
2% 
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alizarin 
MW = 240.21 
Solubility: .4 
mg/mL H2O 
20 mg/mL DMF 
LDH assay: 
Without E: 
100 uM → 5 +/- 
2% 
With E: 
100uM → 20 +/- 
2% 
 
ADH assay 
Without E: 
100uM → 0 +/- 
20% 
With E: 
100uM → 0 +/- 
2% 
 
 
gallic acid 
MW = 170.12 
g/mol 
Solubility: 11.9 
mg/mL H2O 
25 mg/mL DMF 
LDH assay: 
Without E: 
500uM → 5 +/- 
10% 
With E: 
500uM → 2 +/- 
5% 
 
ADH assay 
Without E: 
100uM → 0 +/- 
10% 
With E: 
100uM → 5 +/- 
5% 
 
 
catechin 
MW = 290.271 
g/mol 
Solubility: 100 
mg/mL DMF 
LDH assay: 
Without E: 
100uM → 0 +/- 
15% 
With E: 
100uM → 35 +/- 
5% 
 
ADH assay 
Without E: 
100uM → 0 +/- 
no error 
With E: 
100uM → 20  
 
 EGCG 
MW: 458.4 
g/mol 
Solubility: 25 
mg/mL DMF 
Present in: 
green tea 
Biological 
effect: 
chemopreventio
n 
 
LDH assay: 
Without E: 
100uM → 20 +/- 
5% 
With E: 
100uM → 45 +/- 
2% 
 
ADH assay 
Without E: 
100uM → 0 +/- 
5% 
With E: 
100uM → 10 +/- 
2%  
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T.J.’s Organic Green Tea Extraction: 
1.94g/100mL 
LDH assay: 
Without E: 
Raw extract → 
94 +/- 2% 
With E: 
Raw extract → 
98 +/- 2% 
 
ADH assay 
Without E: 
Raw Extract → 
28 +/- 2% 
With E: 
Raw extract → 
55 +/- 5% 
 
Yogi Green Tea Kombucha
 
Extraction: 
1.94g/100mL 
LDH assay: 
Without E: 
Raw extract → 
50 +/- 8% 
With E: 
Raw extract → 
80 +/- 5% 
 
ADH assay 
Without E: 
Raw Extract → 
15 +/- 3% 
With E: 
Raw extract → 
35 +/- 3% 
 
Clipper Rise and Shine (Herbal)
 
Extraction: 
2.04g/100mL 
LDH assay: 
Without E: 
Raw extract → 0 
+/- 2% 
With E: 
Raw extract → 
78 +/- 2% 
 
ADH assay 
Without E: 
Raw extract → 
0 +/- 7% 
With E: 
Raw extract → 
100 +/- 0.5% 
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Yerba Mate (Herbal)
 
Extraction: 
3.09g/100mL 
LDH assay: 
Without E: 
Raw extract → 7 
+/- 4% 
With E: 
Raw extract → 
78 +/- 2% 
 
ADH assay: 
Without E: 
Raw extract → 
0 +/- 5% 
With E: 
Raw extract → 
100 +/- 1% 
 
PP60 Green Tea Extract 0.2 mg/mL (in 
rxn) 
LDH assay: 
Without E: 
0.2mg/mL → 87 
+/- 4% 
With E: 
0.2mg/mL → 93 
+/- 2% 
 
ADH assay: 
Without E: 
0.2mg/mL → 30 
+/- 25% 
With E: 
0.2mg/mL → 55 
+/- 10% 
 
German Hallertau HOPs (2.5% 
alpha)  
Extraction: 
1.0g/50mL 
LDH assay: 
Without E: 
Raw extract → 
22 +/- 7% 
With E: 
Raw extract → 
84 +/- 2% 
 
ADH assay: 
Without E: 
Raw extract → 
0 +/- 2% 
With E: 
Raw extract → 
55 +/- 5% 
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Cascade HOPs (8.4% alpha, 
7.5% beta)
Extraction: 
1.0g/50mL 
LDH assay: 
Without E: 
Raw extract → 
13 +/- 6% 
With E: 
Raw extract → 
72 +/- 2% 
 
ADH assay: 
Without E: 
Raw extract → 
0 +/- 15% 
With E: 
Raw extract → 
40 +/- 2% 
 
Apollo Hop Pellets (15-19% 
alpha, 5.5-8% beta) 
Extraction: 
1.0g/50mL 
LDH assay: 
Without E: 
Raw extract → 5 
+/- 2% 
With E: 
Raw extract → 
50 +/- 4% 
 
ADH assay: 
Without E: 
Raw extract → 
0 +/- 2% 
With E: 
Raw extract → 
25 +/- 2% 
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Rabbit muscle LDH single subunit amino acid sequence (PDB 3H3F) 
AALKD QLIHN LLKEE HVPQN 
KITVV GVGAV GMACA ISILM 
KDLAD ELALV DVMED KLKGE 
MMDLQ HGSLF LRTPK IVSGK 
DYSVT ANSKL VIITA GARQQ 
EGESR LNLVQ RNVNI FKFII 
PNVVK YSPHC KLLVV SNPVD 
ILTYV AWKIS GFPKN RVIGS  
GCNLD SARFR YLMGE RLGVH 
ALSCH GWILG EHGDS SVPVW 
SGMNV AGVSL KTLHP ELGTD 
ADKEQ WKQVH KQVVD SAYEV 
IKLKG YTTWA IGLSV ADLAE 
SIMKN LRRVH PISTM LKGLY 
GIKED VFLSV PCVLG QNGIS 
DVVKV TLTSE EEAHL KKSAD 
TLWGI QKEL QF 
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Yeast ADH single subunit amino acid sequence (PDB 4W6Z) 
IPETQ KGVIF YESHG KLEYK  
DIPVP KPKAN ELLIN VKYSG 
VCHTD LHAWH GDWPL PVKLP 
LVGGH EGAGV VVGMG ENVKG  
WKIGD YAGIK WLNGS CMACE 
YCELG NESNC PHADL SGYTH 
DGSFQ QYATA DAVQA AHIPQ 
GTDLA QVAPI LCAGI TVYKA  
LKSAN LMAGH WVAIS GAAGG  
LGSLA VQYAK AMGYR VLGID  
GGEGK EELFR SIGGE VFIDF 
TKEKD IVGAV LKATD GGAHG 
VINVS VSEAA IEAST RYVRA 
NGTTV LVGMP AGAKC CSDVF 
NQVVK SISIV GSYVG NRADT 
REALD FFARG LVKSP IKVVG  
LSTLP EIYEK MEKGQ IVGRY VVDTS  
K 
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